Andrea Pace

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Giuseppe Lombardi, Gian Luca De Salvo, Alba A. Brandes et al. · The Lancet Oncology · 2018 · 367 citations

Neuro-oncology, Medicine, Relapsed Glioblastoma +10

Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin Chemotherapy

Andrea Pace, Antonella Savarese, Mauro Picardo et al. · Journal of Clinical Oncology · 2003 · 311 citations

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

Guido Cavaletti, David R. Cornblath, Ingemar S. J. Merkies et al. · Annals of Oncology · 2012 · 284 citations · Full text

Health Sciences, Peripheral Nerve Injury, Pain Medicine +10

Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response

Andrea Pace, Antonello Vidiri, Edvina Galiè et al. · Annals of Oncology · 2003 · 258 citations · Full text

Neuro-oncology, Temozolomide Chemotherapy, Progressive Low-grade Glioma +10

The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy‐induced peripheral neurotoxicity: comparison with the National Cancer Institute‐Common Toxicity Scale

Guido Cavaletti, Barbara Frigeni, Francesca Lanzani et al. · Journal of the Peripheral Nervous System · 2007 · 245 citations